Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000539,LEXF1A/Stm,not specified,365 days to 40 days,26,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,7.7,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70040,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0002455,LEXF1B/Stm,not specified,365 days to 40 days,26,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,0,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70041,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000540,LEXF1C/Stm,not specified,365 days to 40 days,23,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,4.3,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70042,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000541,LEXF2A/Stm,not specified,365 days to 40 days,21,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,71.4,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70043,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000542,LEXF2B/Stm,not specified,365 days to 40 days,20,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,5,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70044,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000543,LEXF2C/Stm,not specified,365 days to 40 days,20,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,10,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70045,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000544,LEXF3/Stm,not specified,365 days to 40 days,26,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,26.9,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70046,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000545,LEXF4/Stm,not specified,365 days to 40 days,21,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,38.1,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70047,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000546,LEXF5/Stm,not specified,365 days to 40 days,19,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,73.7,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70048,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0002447,LEXF6A/Stm,not specified,365 days to 40 days,26,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,26.9,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70049,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000548,LEXF7A/Stm,not specified,365 days to 40 days,25,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,12,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70050,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000549,LEXF7B/Stm,not specified,365 days to 40 days,20,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,40,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70051,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000550,LEXF7C/Stm,not specified,365 days to 40 days,16,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,0,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70052,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000551,LEXF8A/Stm,not specified,365 days to 40 days,17,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,70.6,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70053,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0002450,LEXF8C/Stm,not specified,365 days to 40 days,20,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,75,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70054,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000553,LEXF9/Stm,not specified,365 days to 40 days,27,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,77.8,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70055,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000535,LEXF10A/Stm,not specified,365 days to 40 days,30,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,13.3,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70056,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000536,LEXF10B/Stm,not specified,365 days to 40 days,21,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,0,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70057,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000537,LEXF10C/Stm,not specified,365 days to 40 days,21,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,23.8,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70058,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000538,LEXF11/Stm,not specified,365 days to 40 days,25,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,0,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70059,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000305,F344/DuCrlCrlj,not specified,365 days to 40 days,29,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,0,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70060,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000431,LE/Stm,not specified,365 days to 40 days,26,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,84.6,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70061,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0000552,LEXF8D/Stm,not specified,365 days to 40 days,14,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,35.7,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70062,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0003523,LEXF8B/Stm,not specified,365 days to 40 days,25,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,72,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70620,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days) 1280,"Lu LM, et al., Br J Cancer 1999 May;80(5-6):855-61.",leukocyte integrity trait,,RS:0003521,LEXF2D/Stm,not specified,365 days to 40 days,19,,CMO:0001267,percentage of study population developing leukemia during a period of time,,,,78.9,%,,,MMO:0000538,ex vivo light microscopy with immunohistochemistry,,0.0,light microscopy with immuno,,,,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days),70621,controlled N-propyl-N-nitrosourea content drinking water (400 mg/l) (for 50 days)